Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.

PNNL is the newest member of the CONsortium on Nuclear sECurity Technologies (CONNECT).

Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.

The Joint Appointment program at PNNL is one of the most diverse among other U.S. national laboratories, involving nearly 60 universities and research institutions in the United States and abroad.

Proteins from “auxiliary” genes in soil viruses play a role in the carbon cycle and climate, scientists have found.

A process developed at PNNL that converts biomass and waste into a chemical intermediate or into gasoline, diesel, and jet fuel is available for commercial licensing.

Researchers use machine learning to speed up the analysis of aerosol datasets from mass spectrometry.